Skip to main content

Alpa Laboratories Limited (ALPA.NS)

National Stock Exchange of India Healthcare Drug Manufacturers - Specialty & GenericView data quality →
54.5Fair

ValueMarkers Composite Index

Top 50%#22,245 of 44,707
Undervalued

65% below intrinsic value ($2)

UndervaluedFair ValueOvervalued
Piotroski
3/9
Weak
Beneish
-2.50
Low Risk
Altman
3.63
Safe
DCF Value
$2
Undervalued
ROIC
-1.0%
Low
P/E
12.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Alpa Laboratories Limited (ALPA.NS) — VMCI valuation read

Across 120 indicators, Alpa Laboratories Limited (ALPA.NS) lands at VMCI 55/100. The Healthcare sector median is 50, so the 5-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on ALPA.NS in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, ALPA.NS trades at 23.0x earnings, 28% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -2.0x leaves covenant headroom for ALPA.NS on the trailing balance sheet.

ALPA.NS rose 3.8% over the trailing 7 days, with a -8.6% read on a 30-day basis.

Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.

CEO: Mahendra Singh Chawla410 employeesINwww.alpalabs.in

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in ALPA.NS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.